1. Home
  2. WOLF vs EVO Comparison

WOLF vs EVO Comparison

Compare WOLF & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOLF
  • EVO
  • Stock Information
  • Founded
  • WOLF 1987
  • EVO 1993
  • Country
  • WOLF United States
  • EVO Germany
  • Employees
  • WOLF N/A
  • EVO N/A
  • Industry
  • WOLF Semiconductors
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOLF Technology
  • EVO Health Care
  • Exchange
  • WOLF Nasdaq
  • EVO Nasdaq
  • Market Cap
  • WOLF 200.8M
  • EVO 1.5B
  • IPO Year
  • WOLF 1993
  • EVO 2021
  • Fundamental
  • Price
  • WOLF $1.50
  • EVO $4.20
  • Analyst Decision
  • WOLF Hold
  • EVO Buy
  • Analyst Count
  • WOLF 14
  • EVO 2
  • Target Price
  • WOLF $10.67
  • EVO $5.90
  • AVG Volume (30 Days)
  • WOLF 188.3M
  • EVO 114.3K
  • Earning Date
  • WOLF 08-20-2025
  • EVO 08-13-2025
  • Dividend Yield
  • WOLF N/A
  • EVO N/A
  • EPS Growth
  • WOLF N/A
  • EVO N/A
  • EPS
  • WOLF N/A
  • EVO N/A
  • Revenue
  • WOLF $761,300,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • WOLF N/A
  • EVO $10.08
  • Revenue Next Year
  • WOLF $11.97
  • EVO $10.99
  • P/E Ratio
  • WOLF N/A
  • EVO N/A
  • Revenue Growth
  • WOLF N/A
  • EVO 1.50
  • 52 Week Low
  • WOLF $0.39
  • EVO $2.84
  • 52 Week High
  • WOLF $3.33
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • WOLF 53.98
  • EVO 52.95
  • Support Level
  • WOLF $1.25
  • EVO $4.04
  • Resistance Level
  • WOLF $3.33
  • EVO $4.26
  • Average True Range (ATR)
  • WOLF 0.43
  • EVO 0.11
  • MACD
  • WOLF 0.13
  • EVO -0.01
  • Stochastic Oscillator
  • WOLF 45.92
  • EVO 51.61

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: